averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SPI1
|
ENSG00000066336.7 | Spi-1 proto-oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SPI1 | hg19_v2_chr11_-_47400078_47400127, hg19_v2_chr11_-_47399942_47399961 | 0.59 | 1.3e-21 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_198608146 | 141.46 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr13_-_46756351 | 99.44 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr3_-_121379739 | 86.66 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr12_-_15114603 | 79.79 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr12_-_15114492 | 73.40 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr6_-_32811771 | 64.75 |
ENST00000395339.3
ENST00000374882.3 |
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 |
chr6_-_32160622 | 60.33 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
chr1_-_167487808 | 58.48 |
ENST00000392122.3
|
CD247
|
CD247 molecule |
chr2_+_69001913 | 57.98 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr1_-_167487758 | 57.94 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
chr12_+_54891495 | 57.08 |
ENST00000293373.6
|
NCKAP1L
|
NCK-associated protein 1-like |
chr1_-_183560011 | 56.31 |
ENST00000367536.1
|
NCF2
|
neutrophil cytosolic factor 2 |
chr11_-_58343319 | 55.98 |
ENST00000395074.2
|
LPXN
|
leupaxin |
chr2_+_233925064 | 55.62 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr5_-_169725231 | 55.37 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr11_-_3862206 | 54.92 |
ENST00000351018.4
|
RHOG
|
ras homolog family member G |
chr6_+_31553901 | 53.38 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
chr5_+_169064245 | 53.06 |
ENST00000256935.8
|
DOCK2
|
dedicator of cytokinesis 2 |
chr7_-_5569588 | 52.67 |
ENST00000417101.1
|
ACTB
|
actin, beta |
chr19_+_49838653 | 51.63 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr6_+_32811885 | 51.40 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr17_-_62084241 | 50.05 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
chr1_-_150738261 | 49.57 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr11_+_128563652 | 49.48 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr12_+_7055767 | 49.38 |
ENST00000447931.2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr12_-_118797475 | 49.24 |
ENST00000541786.1
ENST00000419821.2 ENST00000541878.1 |
TAOK3
|
TAO kinase 3 |
chr6_-_31704282 | 49.24 |
ENST00000375784.3
ENST00000375779.2 |
CLIC1
|
chloride intracellular channel 1 |
chr17_+_4618734 | 49.01 |
ENST00000571206.1
|
ARRB2
|
arrestin, beta 2 |
chr12_+_7055631 | 48.85 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr8_+_56792355 | 48.60 |
ENST00000519728.1
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr19_-_10450328 | 48.50 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
chr19_-_10450287 | 47.83 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr6_+_31553978 | 47.52 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
chr1_-_207095324 | 47.39 |
ENST00000530505.1
ENST00000367091.3 ENST00000442471.2 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr2_+_85804614 | 47.09 |
ENST00000263864.5
ENST00000409760.1 |
VAMP8
|
vesicle-associated membrane protein 8 |
chr19_-_8642289 | 46.89 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
chr1_+_111415757 | 46.83 |
ENST00000429072.2
ENST00000271324.5 |
CD53
|
CD53 molecule |
chr2_-_175499294 | 46.54 |
ENST00000392547.2
|
WIPF1
|
WAS/WASL interacting protein family, member 1 |
chr1_-_183559693 | 46.23 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr1_-_25256368 | 44.01 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
chr22_-_37640277 | 43.68 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr6_-_42016385 | 43.26 |
ENST00000502771.1
ENST00000508143.1 ENST00000514588.1 ENST00000510503.1 ENST00000415497.2 ENST00000372988.4 |
CCND3
|
cyclin D3 |
chr12_-_92539614 | 43.16 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chr16_-_88717423 | 42.81 |
ENST00000568278.1
ENST00000569359.1 ENST00000567174.1 |
CYBA
|
cytochrome b-245, alpha polypeptide |
chr14_-_35344093 | 42.63 |
ENST00000382422.2
|
BAZ1A
|
bromodomain adjacent to zinc finger domain, 1A |
chr22_+_37678424 | 42.41 |
ENST00000248901.6
|
CYTH4
|
cytohesin 4 |
chr19_-_36399149 | 42.13 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
chr15_+_75074410 | 40.99 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
chr8_+_56792377 | 40.37 |
ENST00000520220.2
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr2_+_143886877 | 39.57 |
ENST00000295095.6
|
ARHGAP15
|
Rho GTPase activating protein 15 |
chr17_+_43299241 | 38.91 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
chrX_+_128913906 | 38.58 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr19_+_1077393 | 38.37 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr16_-_88717482 | 38.02 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr14_-_23451467 | 37.53 |
ENST00000555074.1
ENST00000361265.4 |
RP11-298I3.5
AJUBA
|
RP11-298I3.5 ajuba LIM protein |
chr14_-_23285011 | 36.97 |
ENST00000397532.3
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr21_-_46340770 | 36.36 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr14_-_23285069 | 35.99 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr12_+_25205666 | 35.82 |
ENST00000547044.1
|
LRMP
|
lymphoid-restricted membrane protein |
chr12_+_25205568 | 35.44 |
ENST00000548766.1
ENST00000556887.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr2_+_68961934 | 34.32 |
ENST00000409202.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr2_+_68961905 | 34.08 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr11_+_60223225 | 33.77 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr11_-_72432950 | 33.41 |
ENST00000426523.1
ENST00000429686.1 |
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr1_-_31230650 | 32.96 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr22_-_37640456 | 32.63 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr2_-_235405168 | 32.46 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr15_+_75074385 | 32.39 |
ENST00000220003.9
|
CSK
|
c-src tyrosine kinase |
chr11_+_60223312 | 32.38 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr17_-_29641104 | 32.25 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr9_-_137809718 | 31.81 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr2_+_109204909 | 31.73 |
ENST00000393310.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr3_+_151986709 | 31.19 |
ENST00000495875.2
ENST00000493459.1 ENST00000324210.5 ENST00000459747.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr11_-_47399942 | 30.95 |
ENST00000227163.4
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr5_-_131826457 | 30.91 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
chr8_+_22438009 | 30.87 |
ENST00000409417.1
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
chr17_+_43299156 | 30.80 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
chr2_-_64371546 | 30.77 |
ENST00000358912.4
|
PELI1
|
pellino E3 ubiquitin protein ligase 1 |
chr15_-_80263506 | 30.65 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr1_+_145439306 | 30.50 |
ENST00000425134.1
|
TXNIP
|
thioredoxin interacting protein |
chr3_-_16555150 | 30.14 |
ENST00000334133.4
|
RFTN1
|
raftlin, lipid raft linker 1 |
chr1_+_9711781 | 30.07 |
ENST00000536656.1
ENST00000377346.4 |
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
chr11_+_65407331 | 29.91 |
ENST00000527525.1
|
SIPA1
|
signal-induced proliferation-associated 1 |
chr7_+_98972298 | 29.80 |
ENST00000252725.5
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr16_+_30484021 | 29.62 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr12_+_25205446 | 29.31 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr2_-_85637459 | 29.05 |
ENST00000409921.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr7_-_115670804 | 28.99 |
ENST00000320239.7
|
TFEC
|
transcription factor EC |
chr6_+_31554826 | 28.97 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chrX_-_47489244 | 28.86 |
ENST00000469388.1
ENST00000396992.3 ENST00000377005.2 |
CFP
|
complement factor properdin |
chr19_-_47220335 | 28.53 |
ENST00000601806.1
ENST00000593363.1 ENST00000598633.1 ENST00000595515.1 ENST00000433867.1 |
PRKD2
|
protein kinase D2 |
chr9_+_77703414 | 28.50 |
ENST00000346234.6
|
OSTF1
|
osteoclast stimulating factor 1 |
chr15_+_77287426 | 28.10 |
ENST00000558012.1
ENST00000267939.5 ENST00000379595.3 |
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr7_-_115670792 | 28.02 |
ENST00000265440.7
ENST00000393485.1 |
TFEC
|
transcription factor EC |
chr3_-_185641681 | 27.85 |
ENST00000259043.7
|
TRA2B
|
transformer 2 beta homolog (Drosophila) |
chr1_+_32716840 | 27.51 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr2_-_96811170 | 27.50 |
ENST00000288943.4
|
DUSP2
|
dual specificity phosphatase 2 |
chr12_-_51718436 | 27.41 |
ENST00000544402.1
|
BIN2
|
bridging integrator 2 |
chr12_+_53848549 | 27.28 |
ENST00000439930.3
ENST00000548933.1 ENST00000562264.1 |
PCBP2
|
poly(rC) binding protein 2 |
chr1_-_207095212 | 26.89 |
ENST00000420007.2
|
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr22_+_37257015 | 26.64 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr16_-_21663919 | 26.37 |
ENST00000569602.1
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr4_+_103423055 | 26.33 |
ENST00000505458.1
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
chr1_+_32739733 | 26.24 |
ENST00000333070.4
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr7_+_74188309 | 26.04 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chr16_+_30483962 | 26.04 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr11_-_47400078 | 25.86 |
ENST00000378538.3
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr6_+_31582961 | 25.85 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
chr8_+_22437965 | 25.69 |
ENST00000409141.1
ENST00000265810.4 |
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
chr1_-_159894319 | 25.61 |
ENST00000320307.4
|
TAGLN2
|
transgelin 2 |
chr17_+_7461781 | 25.36 |
ENST00000349228.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr15_-_40600026 | 25.26 |
ENST00000456256.2
ENST00000557821.1 |
PLCB2
|
phospholipase C, beta 2 |
chr4_-_40631859 | 25.23 |
ENST00000295971.7
ENST00000319592.4 |
RBM47
|
RNA binding motif protein 47 |
chr1_-_111743285 | 25.13 |
ENST00000357640.4
|
DENND2D
|
DENN/MADD domain containing 2D |
chr14_-_24616426 | 24.84 |
ENST00000216802.5
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr11_+_65408273 | 24.81 |
ENST00000394227.3
|
SIPA1
|
signal-induced proliferation-associated 1 |
chr15_+_81589254 | 24.81 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr1_-_159893507 | 24.70 |
ENST00000368096.1
|
TAGLN2
|
transgelin 2 |
chr4_-_174255536 | 24.49 |
ENST00000446922.2
|
HMGB2
|
high mobility group box 2 |
chr17_+_7461580 | 24.44 |
ENST00000483039.1
ENST00000396542.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr16_-_89043377 | 24.34 |
ENST00000436887.2
ENST00000448839.1 ENST00000360302.2 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr8_-_134072593 | 24.30 |
ENST00000427060.2
|
SLA
|
Src-like-adaptor |
chr17_+_72462525 | 24.11 |
ENST00000360141.3
|
CD300A
|
CD300a molecule |
chr17_-_20370847 | 24.10 |
ENST00000423676.3
ENST00000324290.5 |
LGALS9B
|
lectin, galactoside-binding, soluble, 9B |
chr11_+_128563948 | 23.67 |
ENST00000534087.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr2_+_161993412 | 23.60 |
ENST00000259075.2
ENST00000432002.1 |
TANK
|
TRAF family member-associated NFKB activator |
chr17_+_7461613 | 23.52 |
ENST00000438470.1
ENST00000436057.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr19_+_41768401 | 23.25 |
ENST00000352456.3
ENST00000595018.1 ENST00000597725.1 |
HNRNPUL1
|
heterogeneous nuclear ribonucleoprotein U-like 1 |
chr19_+_42381173 | 23.11 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr14_+_102276209 | 22.96 |
ENST00000445439.3
ENST00000334743.5 ENST00000557095.1 |
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma |
chr1_+_32716857 | 22.80 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr2_+_65454926 | 22.77 |
ENST00000542850.1
ENST00000377982.4 |
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast) |
chr2_+_65454863 | 22.77 |
ENST00000260641.5
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast) |
chrX_-_70331298 | 22.60 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr17_+_7461849 | 22.58 |
ENST00000338784.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr11_-_67120974 | 22.45 |
ENST00000539074.1
ENST00000312419.3 |
POLD4
|
polymerase (DNA-directed), delta 4, accessory subunit |
chr8_-_102216925 | 22.33 |
ENST00000517844.1
|
ZNF706
|
zinc finger protein 706 |
chr6_+_89790490 | 22.26 |
ENST00000336032.3
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
chr3_-_18480260 | 22.03 |
ENST00000454909.2
|
SATB1
|
SATB homeobox 1 |
chr12_-_53601055 | 21.96 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
chr6_+_89790459 | 21.89 |
ENST00000369472.1
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
chr4_-_103746683 | 21.86 |
ENST00000504211.1
ENST00000508476.1 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr4_-_103747011 | 21.82 |
ENST00000350435.7
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr16_-_89043605 | 21.75 |
ENST00000268679.4
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr19_+_6772710 | 21.70 |
ENST00000304076.2
ENST00000602142.1 ENST00000596764.1 |
VAV1
|
vav 1 guanine nucleotide exchange factor |
chrX_-_107018969 | 21.59 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr12_-_53601000 | 21.46 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
chr1_+_153330322 | 21.38 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr11_-_72433346 | 21.35 |
ENST00000334211.8
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chrX_-_154688276 | 21.27 |
ENST00000369445.2
|
F8A3
|
coagulation factor VIII-associated 3 |
chrX_+_154114635 | 21.03 |
ENST00000369446.2
|
F8A1
|
coagulation factor VIII-associated 1 |
chr10_-_72362515 | 21.01 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr2_-_153573887 | 21.01 |
ENST00000493468.2
ENST00000545856.1 |
PRPF40A
|
PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
chrX_+_48542168 | 20.94 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
chr11_-_47400062 | 20.90 |
ENST00000533030.1
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr11_-_102323740 | 20.83 |
ENST00000398136.2
|
TMEM123
|
transmembrane protein 123 |
chr8_+_74903580 | 20.83 |
ENST00000284818.2
ENST00000518893.1 |
LY96
|
lymphocyte antigen 96 |
chr21_-_15918618 | 20.55 |
ENST00000400564.1
ENST00000400566.1 |
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1 |
chr7_-_76829125 | 20.54 |
ENST00000248598.5
|
FGL2
|
fibrinogen-like 2 |
chr11_+_75110530 | 20.53 |
ENST00000531188.1
ENST00000530164.1 ENST00000422465.2 ENST00000278572.6 ENST00000534440.1 ENST00000527446.1 ENST00000526608.1 ENST00000527273.1 ENST00000524851.1 |
RPS3
|
ribosomal protein S3 |
chr2_+_109204743 | 20.52 |
ENST00000332345.6
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr2_-_153574480 | 20.51 |
ENST00000410080.1
|
PRPF40A
|
PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
chr4_+_103422471 | 20.44 |
ENST00000226574.4
ENST00000394820.4 |
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
chr4_-_185395672 | 20.40 |
ENST00000393593.3
|
IRF2
|
interferon regulatory factor 2 |
chr10_-_27149851 | 20.39 |
ENST00000376142.2
ENST00000359188.4 ENST00000376139.2 ENST00000376160.1 |
ABI1
|
abl-interactor 1 |
chr2_+_182321925 | 20.35 |
ENST00000339307.4
ENST00000397033.2 |
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr1_-_184943610 | 20.15 |
ENST00000367511.3
|
FAM129A
|
family with sequence similarity 129, member A |
chr16_-_21663950 | 19.97 |
ENST00000268389.4
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr16_-_28506840 | 19.97 |
ENST00000569430.1
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3 |
chr12_-_110888103 | 19.97 |
ENST00000426440.1
ENST00000228825.7 |
ARPC3
|
actin related protein 2/3 complex, subunit 3, 21kDa |
chr19_+_42387228 | 19.72 |
ENST00000354532.3
ENST00000599846.1 ENST00000347545.4 |
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1 |
chr16_+_30205225 | 19.69 |
ENST00000345535.4
ENST00000251303.6 |
SLX1A
|
SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae) |
chr10_-_43892668 | 19.68 |
ENST00000544000.1
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F |
chr17_+_72462766 | 19.50 |
ENST00000392625.3
ENST00000361933.3 ENST00000310828.5 |
CD300A
|
CD300a molecule |
chr16_+_67063142 | 19.49 |
ENST00000412916.2
|
CBFB
|
core-binding factor, beta subunit |
chr10_-_27149904 | 19.42 |
ENST00000376166.1
ENST00000376138.3 ENST00000355394.4 ENST00000346832.5 ENST00000376134.3 ENST00000376137.4 ENST00000536334.1 ENST00000490841.2 |
ABI1
|
abl-interactor 1 |
chr8_-_102217515 | 19.41 |
ENST00000520347.1
ENST00000523922.1 ENST00000520984.1 |
ZNF706
|
zinc finger protein 706 |
chr7_+_99971129 | 19.29 |
ENST00000394000.2
ENST00000350573.2 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
chr16_+_29465822 | 19.23 |
ENST00000330181.5
ENST00000351581.4 |
SLX1B
|
SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) |
chrX_+_11777671 | 19.22 |
ENST00000380693.3
ENST00000380692.2 |
MSL3
|
male-specific lethal 3 homolog (Drosophila) |
chr5_+_35856951 | 19.19 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr14_+_23340822 | 19.16 |
ENST00000359591.4
|
LRP10
|
low density lipoprotein receptor-related protein 10 |
chr16_+_67063036 | 19.12 |
ENST00000290858.6
ENST00000564034.1 |
CBFB
|
core-binding factor, beta subunit |
chr16_+_28505955 | 19.12 |
ENST00000564831.1
ENST00000328423.5 ENST00000431282.1 |
APOBR
|
apolipoprotein B receptor |
chr17_-_34417479 | 19.00 |
ENST00000225245.5
|
CCL3
|
chemokine (C-C motif) ligand 3 |
chr3_-_105588231 | 18.88 |
ENST00000545639.1
ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr4_-_103746924 | 18.61 |
ENST00000505207.1
ENST00000502404.1 ENST00000507845.1 |
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr7_+_99971068 | 18.52 |
ENST00000198536.2
ENST00000453419.1 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
chr10_-_27149792 | 18.07 |
ENST00000376140.3
ENST00000376170.4 |
ABI1
|
abl-interactor 1 |
chr10_-_98031310 | 18.02 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
chr19_+_48248779 | 17.99 |
ENST00000246802.5
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2 |
chr9_-_88969303 | 17.94 |
ENST00000277141.6
ENST00000375963.3 |
ZCCHC6
|
zinc finger, CCHC domain containing 6 |
chrX_+_118602363 | 17.79 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr8_-_101965559 | 17.79 |
ENST00000353245.3
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr7_+_50344289 | 17.66 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr11_+_1874200 | 17.64 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr5_-_142783694 | 17.58 |
ENST00000394466.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr2_+_202125219 | 17.51 |
ENST00000323492.7
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr12_-_120638902 | 17.49 |
ENST00000551150.1
ENST00000313104.5 ENST00000547191.1 ENST00000546989.1 ENST00000392514.4 ENST00000228306.4 ENST00000550856.1 |
RPLP0
|
ribosomal protein, large, P0 |
chr17_-_38721711 | 17.46 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
38.3 | 153.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
29.7 | 89.0 | GO:0070668 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
28.3 | 141.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) bone marrow development(GO:0048539) |
24.7 | 197.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
20.4 | 101.9 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
19.4 | 77.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
18.5 | 55.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
15.9 | 63.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
15.7 | 47.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
15.2 | 45.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
14.7 | 73.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
14.3 | 57.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) actin polymerization-dependent cell motility(GO:0070358) |
13.7 | 54.8 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
12.2 | 73.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
12.0 | 12.0 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
11.7 | 47.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
10.9 | 54.7 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
10.7 | 32.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
10.4 | 124.3 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
10.3 | 30.9 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
10.2 | 30.7 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
9.8 | 49.0 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
9.3 | 46.4 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
9.1 | 36.4 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
9.0 | 36.1 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
8.9 | 143.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
8.9 | 35.6 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
8.8 | 43.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
8.4 | 25.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
7.8 | 23.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
7.8 | 147.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
7.7 | 30.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
7.3 | 51.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
7.2 | 36.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
7.1 | 21.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
7.0 | 27.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
6.9 | 76.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
6.6 | 53.1 | GO:0044351 | macropinocytosis(GO:0044351) |
6.5 | 104.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
6.1 | 127.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
5.8 | 46.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
5.7 | 34.3 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
5.6 | 16.7 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
5.5 | 22.2 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
5.5 | 44.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
5.2 | 25.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
5.1 | 36.0 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
5.1 | 15.2 | GO:0002339 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
4.9 | 34.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
4.9 | 4.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
4.9 | 24.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
4.8 | 33.6 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
4.6 | 18.5 | GO:0030242 | pexophagy(GO:0030242) |
4.5 | 9.1 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
4.4 | 13.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
4.4 | 21.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
4.4 | 13.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
4.3 | 30.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
4.2 | 25.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
4.2 | 25.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.2 | 41.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
4.1 | 12.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
4.0 | 16.1 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
4.0 | 12.0 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
4.0 | 55.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.9 | 30.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
3.8 | 19.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
3.8 | 7.7 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
3.8 | 19.0 | GO:0043307 | eosinophil activation(GO:0043307) |
3.8 | 26.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
3.8 | 112.7 | GO:0045730 | respiratory burst(GO:0045730) |
3.8 | 116.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
3.7 | 18.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
3.7 | 22.0 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
3.7 | 69.7 | GO:0051014 | actin filament severing(GO:0051014) |
3.6 | 3.6 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
3.5 | 13.9 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
3.4 | 13.6 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
3.4 | 26.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
3.3 | 43.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
3.3 | 19.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
3.2 | 42.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
3.1 | 24.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
3.0 | 15.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
3.0 | 12.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
3.0 | 17.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
2.9 | 20.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
2.9 | 11.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
2.9 | 28.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.8 | 56.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
2.8 | 8.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
2.7 | 40.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
2.7 | 8.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
2.7 | 38.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
2.7 | 48.2 | GO:0002347 | response to tumor cell(GO:0002347) |
2.7 | 5.3 | GO:0002384 | hepatic immune response(GO:0002384) |
2.6 | 10.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.5 | 10.2 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
2.5 | 5.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
2.5 | 10.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.5 | 22.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
2.4 | 7.3 | GO:1903772 | ubiquitin-dependent endocytosis(GO:0070086) regulation of viral budding via host ESCRT complex(GO:1903772) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
2.4 | 14.6 | GO:1903800 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
2.4 | 77.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
2.4 | 12.1 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
2.4 | 9.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
2.4 | 9.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
2.4 | 62.1 | GO:0010447 | response to acidic pH(GO:0010447) |
2.3 | 58.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
2.3 | 18.0 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
2.2 | 55.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
2.2 | 37.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
2.1 | 20.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
2.0 | 6.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.0 | 5.9 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
2.0 | 37.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
2.0 | 3.9 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
1.9 | 21.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.9 | 5.8 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.9 | 42.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
1.8 | 25.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.8 | 24.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.8 | 3.5 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
1.7 | 10.5 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
1.7 | 12.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
1.7 | 27.4 | GO:0097320 | membrane tubulation(GO:0097320) |
1.7 | 23.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
1.7 | 13.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.7 | 8.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
1.7 | 1.7 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.7 | 5.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.7 | 210.8 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.7 | 18.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.7 | 36.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.6 | 13.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
1.6 | 94.5 | GO:0045576 | mast cell activation(GO:0045576) |
1.6 | 25.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
1.6 | 236.6 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
1.6 | 11.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.5 | 4.6 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
1.5 | 4.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
1.5 | 7.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
1.5 | 59.5 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
1.4 | 19.9 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
1.4 | 5.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.4 | 13.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.4 | 6.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.4 | 100.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
1.4 | 31.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.4 | 12.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.4 | 4.1 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
1.4 | 12.2 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
1.3 | 34.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.3 | 9.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
1.3 | 10.1 | GO:0006116 | NADH oxidation(GO:0006116) |
1.3 | 13.9 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.3 | 8.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.2 | 17.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.2 | 3.7 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
1.2 | 50.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.2 | 8.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.2 | 3.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.2 | 13.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.2 | 8.2 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.2 | 17.5 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
1.2 | 7.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
1.2 | 29.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
1.2 | 5.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.2 | 8.1 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
1.1 | 3.4 | GO:0018201 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
1.1 | 27.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
1.1 | 19.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.1 | 16.8 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
1.1 | 53.4 | GO:0042100 | B cell proliferation(GO:0042100) |
1.1 | 7.8 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.1 | 3.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
1.1 | 7.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.1 | 6.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.1 | 88.6 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
1.1 | 4.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.1 | 153.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
1.1 | 14.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.0 | 12.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
1.0 | 5.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
1.0 | 17.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
1.0 | 10.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.0 | 12.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.0 | 5.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.9 | 12.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.9 | 28.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.9 | 26.7 | GO:0006266 | DNA ligation(GO:0006266) |
0.9 | 4.5 | GO:0019230 | proprioception(GO:0019230) |
0.9 | 11.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.9 | 6.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.9 | 58.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.9 | 2.6 | GO:0060613 | fat pad development(GO:0060613) |
0.8 | 5.0 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.8 | 11.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.8 | 12.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.8 | 29.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.8 | 14.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.8 | 12.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.8 | 1.5 | GO:0061056 | sclerotome development(GO:0061056) |
0.8 | 12.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.7 | 95.8 | GO:0007338 | single fertilization(GO:0007338) |
0.7 | 18.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 | 5.8 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.7 | 104.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.7 | 7.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 22.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.7 | 3.5 | GO:0021759 | globus pallidus development(GO:0021759) |
0.7 | 9.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.7 | 9.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.7 | 2.0 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.7 | 2.0 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.6 | 5.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.6 | 21.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.6 | 6.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.6 | 35.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.6 | 0.6 | GO:2000137 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.6 | 24.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 2.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.6 | 6.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.6 | 3.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.5 | 24.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 15.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 20.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.5 | 4.8 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.5 | 11.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.5 | 4.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.5 | 15.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.5 | 9.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 7.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 4.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 2.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 1.9 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.4 | 1.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 17.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 5.5 | GO:0017145 | stem cell division(GO:0017145) |
0.4 | 78.3 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.4 | 7.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 1.1 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.4 | 2.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.3 | 3.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 39.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 11.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 2.5 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.3 | 6.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 5.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.3 | 43.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 5.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 1.8 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 2.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.3 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.3 | 17.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.3 | 20.4 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 9.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.3 | 8.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 0.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 20.2 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 4.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 4.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 4.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 9.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 4.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 17.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 8.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 8.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 4.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 6.1 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 4.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 2.3 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.2 | 7.1 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.2 | 2.1 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 11.8 | GO:0042113 | B cell activation(GO:0042113) |
0.2 | 0.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 3.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 2.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 1.5 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.2 | 23.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.2 | 1.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 9.2 | GO:0048678 | response to axon injury(GO:0048678) |
0.2 | 40.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.2 | 6.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 8.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 3.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 1.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 5.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 1.6 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 2.1 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 3.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.6 | GO:0097480 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.1 | 1.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 1.0 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.1 | 0.4 | GO:0032048 | cardiolipin metabolic process(GO:0032048) cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 0.7 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.2 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 1.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.9 | GO:0010659 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) |
0.1 | 0.8 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 1.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 10.4 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.0 | 1.0 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 2.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 2.9 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 1.5 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.6 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 1.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 2.1 | GO:0001503 | ossification(GO:0001503) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.6 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 1.1 | GO:0008033 | tRNA processing(GO:0008033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.5 | 236.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
19.4 | 155.2 | GO:0032010 | phagolysosome(GO:0032010) |
17.8 | 89.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
15.9 | 63.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
15.3 | 92.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
14.5 | 116.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
11.1 | 55.4 | GO:0036398 | TCR signalosome(GO:0036398) |
9.6 | 19.1 | GO:0042627 | chylomicron(GO:0042627) |
9.2 | 55.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
9.0 | 125.9 | GO:0031209 | SCAR complex(GO:0031209) |
8.2 | 164.3 | GO:0001891 | phagocytic cup(GO:0001891) |
7.8 | 102.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
7.1 | 49.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
6.9 | 27.5 | GO:0097422 | tubular endosome(GO:0097422) |
6.8 | 20.5 | GO:0071159 | NF-kappaB complex(GO:0071159) |
6.4 | 31.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
6.1 | 6.1 | GO:1902911 | serine/threonine protein kinase complex(GO:1902554) protein kinase complex(GO:1902911) |
5.7 | 34.3 | GO:0071817 | MMXD complex(GO:0071817) |
5.6 | 22.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
5.4 | 26.8 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
5.3 | 37.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
5.0 | 95.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
5.0 | 50.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
5.0 | 34.8 | GO:0072487 | MSL complex(GO:0072487) |
4.2 | 12.5 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
4.1 | 69.7 | GO:0032059 | bleb(GO:0032059) |
4.1 | 52.7 | GO:0097433 | dense body(GO:0097433) |
4.0 | 216.8 | GO:0001772 | immunological synapse(GO:0001772) |
3.9 | 42.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
3.8 | 15.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
3.8 | 11.4 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
3.7 | 22.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
3.6 | 32.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
3.3 | 10.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
3.3 | 49.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
3.2 | 16.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
3.1 | 12.2 | GO:0005687 | U4 snRNP(GO:0005687) |
3.0 | 21.0 | GO:0044194 | cytolytic granule(GO:0044194) |
2.9 | 46.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.8 | 22.6 | GO:0042382 | paraspeckles(GO:0042382) |
2.8 | 22.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
2.5 | 44.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.5 | 9.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.2 | 32.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.2 | 13.1 | GO:1990037 | Lewy body core(GO:1990037) |
2.2 | 167.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
2.1 | 29.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
2.0 | 13.9 | GO:0030870 | Mre11 complex(GO:0030870) |
1.9 | 13.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.9 | 13.3 | GO:0016272 | prefoldin complex(GO:0016272) |
1.9 | 13.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.9 | 7.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
1.8 | 10.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.7 | 55.0 | GO:0005685 | U1 snRNP(GO:0005685) |
1.6 | 8.2 | GO:0000125 | PCAF complex(GO:0000125) |
1.6 | 14.6 | GO:0032039 | integrator complex(GO:0032039) |
1.6 | 4.8 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
1.6 | 1.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
1.6 | 11.0 | GO:0097452 | GAIT complex(GO:0097452) |
1.5 | 132.6 | GO:0035580 | specific granule lumen(GO:0035580) |
1.5 | 4.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.4 | 5.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.4 | 15.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.4 | 6.9 | GO:0032021 | NELF complex(GO:0032021) |
1.4 | 8.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.3 | 94.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
1.3 | 5.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.3 | 5.3 | GO:0032044 | DSIF complex(GO:0032044) |
1.2 | 8.7 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
1.2 | 16.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.2 | 45.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.2 | 5.9 | GO:0033263 | CORVET complex(GO:0033263) |
1.2 | 15.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 11.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.1 | 7.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.1 | 45.2 | GO:0002102 | podosome(GO:0002102) |
1.1 | 15.1 | GO:0042588 | zymogen granule(GO:0042588) |
1.1 | 8.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.0 | 7.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.0 | 113.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.0 | 5.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.0 | 17.5 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 11.6 | GO:0030008 | TRAPP complex(GO:0030008) |
1.0 | 4.8 | GO:0032009 | early phagosome(GO:0032009) |
1.0 | 5.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.9 | 12.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.9 | 9.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.9 | 3.6 | GO:0055087 | Ski complex(GO:0055087) |
0.9 | 274.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.9 | 7.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.9 | 7.0 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.8 | 5.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.8 | 5.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.8 | 112.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.8 | 5.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
0.8 | 6.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.8 | 4.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 2.4 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.8 | 2.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.7 | 12.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.7 | 69.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.7 | 12.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 5.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.7 | 50.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.7 | 8.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.7 | 34.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.7 | 53.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.7 | 97.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.7 | 6.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 1.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 100.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.6 | 34.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.6 | 18.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.5 | 21.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 18.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 11.5 | GO:0031105 | septin complex(GO:0031105) |
0.5 | 14.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.5 | 28.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 2.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 12.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.5 | 7.7 | GO:0036452 | ESCRT complex(GO:0036452) |
0.4 | 10.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 1.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 27.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 9.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.4 | 4.0 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.4 | 6.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 34.2 | GO:0005884 | actin filament(GO:0005884) |
0.4 | 2.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 29.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.3 | 2.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 122.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 6.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 53.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 3.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 22.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 2.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 5.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 13.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 7.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 3.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 22.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.3 | 145.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 30.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.2 | 6.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 10.6 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 22.9 | GO:0016605 | PML body(GO:0016605) |
0.2 | 52.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 4.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 2.8 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.2 | 3.2 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 4.3 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 17.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 9.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 4.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 2.3 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.6 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 1.1 | GO:0070187 | telosome(GO:0070187) |
0.1 | 8.9 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 9.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 548.0 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 4.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 8.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 2.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 5.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 3.8 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) |
0.0 | 4.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.5 | 55.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
16.3 | 49.0 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
15.3 | 153.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
13.9 | 41.8 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
13.8 | 96.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
13.3 | 133.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
13.1 | 92.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
12.8 | 76.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
12.7 | 51.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
10.9 | 32.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
10.7 | 74.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
10.4 | 31.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
9.2 | 55.4 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
9.2 | 27.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
8.4 | 25.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
8.1 | 146.4 | GO:0005522 | profilin binding(GO:0005522) |
7.8 | 211.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
7.1 | 21.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
7.1 | 77.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
6.6 | 19.9 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
6.6 | 26.3 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
6.6 | 19.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
6.4 | 25.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
6.3 | 38.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
6.3 | 69.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
6.0 | 102.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
5.4 | 26.8 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
5.1 | 56.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
4.5 | 67.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
4.1 | 57.9 | GO:0030957 | Tat protein binding(GO:0030957) |
4.1 | 12.3 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
3.9 | 116.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
3.8 | 15.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.8 | 11.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
3.8 | 19.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
3.7 | 56.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
3.7 | 118.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
3.7 | 22.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
3.5 | 28.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
3.5 | 17.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
3.4 | 6.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
3.4 | 43.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
3.2 | 22.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
3.0 | 15.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
3.0 | 57.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.9 | 132.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
2.9 | 23.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.9 | 8.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.9 | 8.7 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.9 | 11.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
2.7 | 19.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.7 | 31.8 | GO:0033691 | sialic acid binding(GO:0033691) |
2.6 | 10.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
2.5 | 20.4 | GO:1990405 | protein antigen binding(GO:1990405) |
2.5 | 10.2 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
2.5 | 17.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
2.5 | 74.9 | GO:0023026 | MHC protein complex binding(GO:0023023) MHC class II protein complex binding(GO:0023026) |
2.5 | 32.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.4 | 14.6 | GO:0035500 | MH2 domain binding(GO:0035500) |
2.4 | 21.6 | GO:0043426 | MRF binding(GO:0043426) |
2.4 | 31.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
2.4 | 40.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
2.3 | 7.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
2.3 | 57.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
2.3 | 142.9 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
2.2 | 56.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.2 | 44.8 | GO:0051400 | BH domain binding(GO:0051400) |
2.2 | 31.2 | GO:0003680 | AT DNA binding(GO:0003680) |
2.2 | 33.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
2.2 | 12.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
2.1 | 29.6 | GO:0019864 | IgG binding(GO:0019864) |
2.1 | 16.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
2.0 | 12.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
1.9 | 13.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.9 | 3.9 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
1.9 | 7.8 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
1.9 | 7.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.9 | 9.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.8 | 5.5 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
1.8 | 5.3 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.8 | 8.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
1.8 | 7.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.7 | 12.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.7 | 13.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.7 | 6.9 | GO:0016936 | galactoside binding(GO:0016936) |
1.7 | 15.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.7 | 8.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
1.7 | 11.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.7 | 24.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.6 | 8.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.6 | 4.8 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.6 | 73.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.6 | 28.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.6 | 31.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.6 | 17.1 | GO:0034452 | dynactin binding(GO:0034452) |
1.5 | 9.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.5 | 6.0 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
1.5 | 28.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.5 | 32.2 | GO:0000339 | RNA cap binding(GO:0000339) |
1.5 | 49.6 | GO:0043236 | laminin binding(GO:0043236) |
1.4 | 37.3 | GO:0031489 | myosin V binding(GO:0031489) |
1.4 | 5.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.4 | 8.4 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
1.4 | 20.9 | GO:0043274 | phospholipase binding(GO:0043274) |
1.4 | 13.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.3 | 44.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.3 | 5.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.2 | 14.9 | GO:0045159 | myosin II binding(GO:0045159) |
1.2 | 3.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.2 | 38.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.2 | 62.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.2 | 112.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.2 | 40.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.2 | 38.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
1.1 | 6.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.1 | 3.4 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.1 | 19.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.1 | 6.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.1 | 9.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.1 | 66.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.0 | 11.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.0 | 3.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
1.0 | 49.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
1.0 | 24.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.9 | 15.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.9 | 93.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.9 | 20.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.9 | 2.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.9 | 12.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.9 | 211.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.9 | 8.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.9 | 52.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.9 | 6.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.9 | 4.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.9 | 13.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 21.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.9 | 19.1 | GO:0005521 | lamin binding(GO:0005521) |
0.9 | 15.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.8 | 18.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.8 | 31.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.8 | 5.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.8 | 109.6 | GO:0005178 | integrin binding(GO:0005178) |
0.8 | 21.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.8 | 4.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.8 | 241.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.8 | 22.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.8 | 25.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.8 | 7.7 | GO:0046790 | virion binding(GO:0046790) |
0.8 | 4.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 13.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.7 | 15.4 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.7 | 11.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 3.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.7 | 7.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.7 | 148.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.7 | 39.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.7 | 3.3 | GO:0019003 | GDP binding(GO:0019003) |
0.6 | 187.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.6 | 18.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 2.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 8.5 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.6 | 1.7 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.5 | 4.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 2.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.5 | 18.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 4.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 12.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.5 | 28.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.5 | 7.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 5.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 10.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 2.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 7.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.5 | 18.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 52.0 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.5 | 14.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 2.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 4.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 7.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 0.8 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.4 | 6.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 9.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 2.0 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.4 | 48.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.4 | 9.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 9.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 1.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.4 | 17.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 22.1 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.4 | 4.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 12.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 1.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.3 | 17.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 5.8 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 84.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.3 | 1.5 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.3 | 3.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 21.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 13.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 5.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 4.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 29.3 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 9.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 9.4 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 3.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 2.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 6.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 4.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 41.8 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 3.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 2.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 2.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 4.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 15.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 2.1 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.5 | GO:0030346 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) protein phosphatase 2B binding(GO:0030346) |
0.0 | 3.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 1.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 2.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 684.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
6.1 | 280.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
4.7 | 407.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
4.5 | 316.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
4.3 | 225.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.9 | 17.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.8 | 42.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.6 | 186.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.6 | 23.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.5 | 73.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
2.1 | 49.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
2.1 | 33.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
2.1 | 150.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.0 | 66.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.7 | 47.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.7 | 163.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.6 | 16.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.6 | 61.6 | PID BCR 5PATHWAY | BCR signaling pathway |
1.5 | 20.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.4 | 211.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.3 | 38.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.2 | 32.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.2 | 29.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.1 | 27.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.1 | 5.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.1 | 15.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.1 | 17.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.0 | 9.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.0 | 35.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.9 | 22.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.9 | 5.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 17.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 3.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 51.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.7 | 22.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.6 | 7.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 54.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.5 | 12.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 39.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.4 | 19.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 5.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 11.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 10.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 7.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 5.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 10.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 4.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.1 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 4.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 5.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 3.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 2.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 2.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.7 | PID P73PATHWAY | p73 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.4 | 98.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
15.9 | 429.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
5.8 | 253.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
5.4 | 310.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
5.0 | 49.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
4.3 | 349.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
4.2 | 67.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
4.0 | 19.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
3.2 | 41.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
2.9 | 17.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
2.7 | 52.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
2.6 | 28.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.4 | 65.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.2 | 368.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
2.2 | 315.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
2.2 | 55.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.2 | 44.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
2.2 | 50.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.0 | 47.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
2.0 | 23.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
2.0 | 61.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.9 | 22.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.9 | 54.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.8 | 59.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.8 | 38.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.7 | 65.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
1.5 | 38.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.5 | 21.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.5 | 51.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.4 | 56.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.4 | 16.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.4 | 23.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.4 | 103.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.3 | 22.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.3 | 49.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.3 | 31.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.3 | 22.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.3 | 25.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.3 | 40.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.2 | 9.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.2 | 7.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.2 | 46.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.2 | 28.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.1 | 66.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 6.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.1 | 5.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.0 | 8.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.0 | 13.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.0 | 101.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.0 | 45.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.9 | 16.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.8 | 124.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.8 | 13.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 8.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.7 | 10.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.7 | 13.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.7 | 14.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.7 | 10.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 5.7 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.6 | 16.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.6 | 10.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 5.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 11.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 6.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 21.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 5.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 12.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 17.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.5 | 22.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 10.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 10.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 9.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 7.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 5.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 15.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 26.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 6.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 17.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 14.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 7.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 12.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 5.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 4.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 17.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 3.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 5.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 2.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 5.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 1.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 3.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |